Skip to content

Clinical trials

Completed Breast Neoplasms trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Peru Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20022
20036
20045
20051
20065
20075
20084
20096
20104
20116
20127
20132
20144
20153
20182
20193
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche16
Novartis Pharmaceuticals11
ETOP IBCSG Partners Foundation7
GlaxoSmithKline6
AstraZeneca4
Bristol-Myers Squibb3
Pfizer3
Boehringer Ingelheim2
Eli Lilly and Company2
Genentech, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms72
Neoplasm Metastasis9
Neoplasms4
Triple Negative Breast Neoplasms3
Inflammatory Breast Neoplasms2
Bone Diseases, Metabolic1
Brain Neoplasms1
Breast Diseases1
Infertility1
Multiple Endocrine Neoplasia Type 11

Trials

Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.